| No. |
MP |
Dosage form |
Manufacturer |
PR description |
| 1 |
DIPROFOL® |
emulsion for injection 1% in 20 ml ampoules; 5 ampoules per blister; 1 blister per cardboard pack; 50 ml in a vial; 1 vial per cardboard pack |
PJSC “Farmak” (packaging from in bulk form of the manufacturer Synthon Hispania, S.L., Spain (at the production site of Fresenius Kabi Austria GmbH, Austria) |
During the surgical intervention, after the start of the infusion of Diprofol solution, marked hypertension (200-220/130-140 mm Hg), tachycardia up to 140-150 bpm, hyperthermia up to 38 °C, and skin manifestations in the form of facial and chest hyperemia were observed |
| 2 |
LARNAMIN |
concentrate for solution for infusion, 500 mg/mL; 10 mL in an ampoule; 5 or 10 ampoules in a cardboard pack; 10 mL in an ampoule; 5 ampoules in a blister; 1 or 2 blisters in a cardboard pack |
PJSC “Farmak” |
After taking the medicinal product “Larnamin”, dizziness and palpitations appeared |
| 3 |
METACARTIN |
solution for injection, 1 g/5 ml, 5 ml in an ampoule; 5 ampoules in a blister pack; 1 or 2 blister packs in a cardboard box |
Mefar Ilac San. A.S. |
Skin itching and skin rash |
| 4 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL or 200 mL or 400 mL in bottles; 100 mL or 200 mL or 250 mL or 400 mL or 500 mL or 1000 mL or 2000 mL or 3000 mL or 5000 mL in polymer containers |
LLC “Yuria-Pharm” |
increase in temperature to 38.6°C, chills, headache |
| 5 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL or 200 mL or 400 mL in bottles; 100 mL or 200 mL or 250 mL or 400 mL or 500 mL or 1000 mL or 2000 mL or 3000 mL or 5000 mL in polymer containers |
LLC “Yuria-Pharm” |
body temperature rise to 37.5°C, chills, general weakness, blood pressure increase 180/100 mm Hg |
| 6 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL or 200 mL or 400 mL in bottles; 100 mL or 200 mL or 250 mL or 400 mL or 500 mL or 1000 mL or 2000 mL or 3000 mL or 5000 mL in polymer containers |
LLC “Yuria-Pharm” |
body temperature increase to 39.2°C, chills, general weakness |
| 7 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL or 200 mL or 400 mL in bottles; 100 mL or 200 mL or 250 mL or 400 mL or 500 mL or 1000 mL or 2000 mL or 3000 mL or 5000 mL in polymer containers |
LLC “Yuria-Pharm” |
After intravenous infusion: general weakness, a rise in body temperature to 39.8 C and a drop in blood pressure. |
| 8 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL or 200 mL or 400 mL in bottles; 100 mL or 200 mL or 250 mL or 400 mL or 500 mL or 1000 mL or 2000 mL or 3000 mL or 5000 mL in polymer containers |
LLC “Yuria-Pharm” |
After administration of the drug, the patient developed: marked general weakness, headache, chills and a rise in body temperature to 39.0 C. |
| 9 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL or 200 mL or 400 mL in bottles; 100 mL or 200 mL or 250 mL or 400 mL or 500 mL or 1000 mL or 2000 mL or 3000 mL or 5000 mL in polymer containers |
LLC “Yuria-Pharm” |
After administration of the drug, the patient developed: headache and a rise in body temperature to 39.0 C. |
| 10 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL or 200 mL or 400 mL in bottles; 100 mL or 200 mL or 250 mL or 400 mL or 500 mL or 1000 mL or 2000 mL or 3000 mL or 5000 mL in polymer containers |
LLC “Yuria-Pharm” |
After administration of the medicinal product, the patient developed: headache, tremor and a rise in body temperature to 39.5 C. |
| 11 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL or 200 mL or 400 mL in bottles; 100 mL or 200 mL or 250 mL or 400 mL or 500 mL or 1000 mL or 2000 mL or 3000 mL or 5000 mL in polymer containers |
LLC “Yuria-Pharm” |
After administration of the drug, the patient developed: headache, tremor, body temperature increase to 39,5 C and nausea. |
| 12 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL or 200 mL or 400 mL in bottles; 100 mL or 200 mL or 250 mL or 400 mL or 500 mL or 1000 mL or 2000 mL or 3000 mL or 5000 mL in polymer containers |
LLC “Yuria-Pharm” |
After administration of the medicinal product, the patient developed general weakness, headache, chills and a rise in body temperature to 39.0 C. |
| 13 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL or 200 mL or 400 mL in bottles; 100 mL or 200 mL or 250 mL or 400 mL or 500 mL or 1000 mL or 2000 mL or 3000 mL or 5000 mL in polymer containers |
LLC “Yuria-Pharm” |
After administration of the medicinal product, the patient developed general weakness, headache, chills and a rise in body temperature to 40.0 C. |
| 14 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL or 200 mL or 400 mL in bottles; 100 mL or 200 mL or 250 mL or 400 mL or 500 mL or 1000 mL or 2000 mL or 3000 mL or 5000 mL in polymer containers |
LLC “Yuria-Pharm” |
After administration of the drug, the patient developed: general weakness, headache, tremor, chills and a rise in body temperature to 38.6 C. |
| 15 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL or 200 mL or 400 mL in bottles; 100 mL or 200 mL or 250 mL or 400 mL or 500 mL or 1000 mL or 2000 mL or 3000 mL or 5000 mL in polymer containers |
LLC “Yuria-Pharm” |
After administration of the medicinal product, the patient developed general weakness, headaches, chills and a rise in body temperature to 39.0 C. |
| 16 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL or 200 mL or 400 mL in bottles; 100 mL or 200 mL or 250 mL or 400 mL or 500 mL or 1000 mL or 2000 mL or 3000 mL or 5000 mL in polymer containers |
LLC “Yuria-Pharm” |
After administration of the drug, the patient developed chills and a rise in body temperature to 39.4 C. |
| 17 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL or 200 mL or 400 mL in bottles; 100 mL or 200 mL or 250 mL or 400 mL or 500 mL or 1000 mL or 2000 mL or 3000 mL or 5000 mL in polymer containers |
LLC “Yuria-Pharm” |
skin redness, difficulty breathing, increased BP 220/100 mm Hg |
| 18 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL or 200 mL or 400 mL in bottles; 100 mL or 200 mL or 250 mL or 400 mL or 500 mL or 1000 mL or 2000 mL or 3000 mL or 5000 mL in polymer containers |
LLC “Yuria-Pharm” |
itching, redness of the entire trunk |
| 19 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL, or 200 mL, or 250 mL, or 400 mL, or 500 mL in a bottle; 1 bottle in a cardboard box; 100 mL, 200 mL or 250 mL, or 400 mL, or 500 mL in bottles |
Limited Liability Company firm "Novofarm-Biosyntez" |
increase in body temperature to 39,5 C, increased blood pressure (170/100 mm Hg) , tremor, chills |
| 20 |
SODIUM CHLORIDE |
solution for infusion, 9 mg/mL, 100 mL, or 200 mL, or 250 mL, or 400 mL, or 500 mL in a bottle; 1 bottle in a cardboard box; 100 mL, 200 mL or 250 mL, or 400 mL, or 500 mL in bottles |
Limited Liability Company firm "Novofarm-Biosyntez" |
increase in body temperature to 39,5 C, increased blood pressure (180 mm Hg), tremor, chills |
| 21 |
SODIUM CHLORIDE SOLUTION 0,9 % |
solution for infusion 0,9% in 100 ml, or 200 ml, or 250 ml, or 400 ml, or 500 ml in bottles |
Private Joint-Stock Company “Infuzia” |
02.08.2019 during intravenous drip infusion of 150 ml of the medicinal product Sodium Chloride, the child developed manifestations of an AR: body temperature rise to 40,7° C, chills. The infusion therapy was discontinued. The manifestations of the AR disappeared after withdrawal of the suspected medicinal product and administration of drug therapy to eliminate the manifestations of the AR: Analgin 0,5 ml and Papaverine 0,5 ml were administered intramuscularly. Other concomitant therapy was continued in subsequent treatment without adverse consequences. |
| 22 |
SODIUM CHLORIDE SOLUTION 0,9 % |
solution for infusion 0,9% in 100 ml, or 200 ml, or 250 ml, or 400 ml, or 500 ml in bottles |
Private Joint-Stock Company “Infuzia” |
03.08.2019 during intravenous drip administration of 200 ml of the medicinal product Sodium chloride, the patient developed adverse reaction manifestations: body temperature increased to 38,9° C, fine tremor, lethargy, acrocyanosis, extremities cool to the touch. Infusion therapy was discontinued. The adverse reaction manifestations resolved within an hour after withdrawal of the suspected medicinal product and administration of drug therapy to eliminate the manifestations: Analgin 0,8 ml, Papaverine 0,8 ml, Diphenhydramine 0,8 ml were administered intramuscularly. Other concomitant therapy was continued in subsequent treatment without adverse consequences. increase in body temperature to 38,9 C, lethargy, acrocyanosis, tremor |
| 23 |
SODIUM CHLORIDE SOLUTION 0,9 % |
solution for infusion 0,9% in 100 ml, or 200 ml, or 250 ml, or 400 ml, or 500 ml in bottles |
Private Joint-Stock Company “Infuzia” |
03.08.2019 during intravenous drip infusion of 50 ml of the medicinal product Sodium chloride, the patient developed manifestations of an adverse reaction: body temperature rise to 39,8°C, chills, dyspnea, tachycardia, acrocyanosis, pallor of the skin and mucous membranes. The infusion therapy was stopped. The manifestations of the adverse reaction disappeared within an hour after withdrawal of the suspected medicinal product and administration of drug therapy to eliminate them: Suprastin 0,4 ml and dexazon 0,5 ml were administered i.m. Other concomitant therapy was continued afterwards without adverse consequences. |
| 24 |
SODIUM CHLORIDE SOLUTION 0,9 % |
solution for infusion 0,9% in 100 ml, or 200 ml, or 250 ml, or 400 ml, or 500 ml in bottles |
Private Joint-Stock Company “Infuzia” |
03.08.2019 during an intravenous drip infusion of 200 mL of Sodium Chloride medicinal product, the child developed manifestations of an AR: body temperature rose to 39,4° C, chills, restlessness, pallor of the skin and mucous membranes. The extremities were cool to the touch. The infusion therapy was stopped. The manifestations of the AR disappeared after withdrawal of the suspected medicinal product and administration of drug therapy to eliminate the manifestations of the AR. Other concomitant therapy was continued in subsequent treatment without negative consequences. |
| 25 |
SODIUM CHLORIDE SOLUTION 0,9 % |
solution for infusion 0,9% in 100 ml, or 200 ml, or 250 ml, or 400 ml, or 500 ml in bottles |
Private Joint-Stock Company “Infuzia” |
Headache, general weakness, chills, increase in body temperature (t) to 39,2C |
| 26 |
SODIUM CHLORIDE SOLUTION 0,9 % |
solution for infusion 0,9% in 100 ml, or 200 ml, or 250 ml, or 400 ml, or 500 ml in bottles |
Private Joint-Stock Company “Infuzia” |
General weakness, chills, increase in body temperature to 39,4C |
| 27 |
SODIUM CHLORIDE SOLUTION 0,9 % |
solution for infusion 0,9% in 100 ml, or 200 ml, or 250 ml, or 400 ml, or 500 ml in bottles |
Private Joint-Stock Company “Infuzia” |
Body temperature increase to 40C, general weakness |
| 28 |
RINGER'S SOLUTION |
solution for infusion, 200 ml or 400 ml in bottles |
Private Joint-Stock Company “Infuzia” |
Trembling and a feeling of heat in the body, body temperature rising to 38 degrees |
|
